Condition
Avascular Necrosis of the Head of Humerus
Total Trials
7
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown3
Completed2
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07558590Recruiting
RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
NCT04968405Not ApplicableCompleted
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
NCT05868148Active Not Recruiting
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
NCT02679352Not ApplicableCompleted
SMR Stemless Shoulder Arthroplasty Clinical Study
NCT03806842Not ApplicableUnknown
Easytech Reversed Shoulder System Clinical Study
NCT02444299Unknown
Aequalis Resurfacing Head Study
NCT02424760Unknown
Clinical Outcomes in Shoulder Hemi-arthroplasty Using a PyC Spherical Interpositional Implant
Showing all 7 trials